Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 270 participants.

Also called NCT01736735

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 270 participants (planned count) (from the registry)
Sponsor
Sorbent Therapeutics (from the registry)
Registry
  • NCT NCT01736735
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01736735. Randomized; double masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Acronym
STEPWISE
Condition
Heart Failure
Intervention (Drug)
CLP
Intervention (Drug)
placebo
Lead sponsor
Sorbent Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct01736735
Content hash
7c0c8c7ca8527a26846725daa7f0c2b39a3092367833014de77465377dda9fa3